Visual and Anatomical Outcomes of Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration

A retrospective chart review of patients with persistent subretinal and/or intraretinal fluid, despite previous treatment with intravitreal ranibizumab (0.5 mg), who were switched to aflibercept injections, was performed. Treatment was three monthly aflibercept (2 mg) injections followed by dosing o...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Gharbiya, Magda, Iannetti, Ludovico, Parisi, Francesco, De Vico, Umberto, Mungo, Maria Laura, Marenco, Marco
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2014
Matèries:
Clinical Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4033502/
https://ncbi.nlm.nih.gov/pubmed/24895562
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/273754
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars